Edition:
United States

AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

3.35USD
22 Sep 2017
Change (% chg)

$0.15 (+4.69%)
Prev Close
$3.20
Open
$3.20
Day's High
$3.35
Day's Low
$3.15
Volume
820,336
Avg. Vol
1,054,897
52-wk High
$4.08
52-wk Low
$1.95

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.27 December 23 Sep 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 3 3 3
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.17 2.17 2.17 2.17

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 6 2.22 3.80 0.10 0.89
Quarter Ending Dec-17 6 2.84 6.10 0.30 0.94
Year Ending Dec-17 6 10.65 15.70 5.60 7.41
Year Ending Dec-18 6 29.70 41.70 3.90 53.66
Earnings (per share)
Quarter Ending Sep-17 6 -0.27 -0.22 -0.30 -0.23
Quarter Ending Dec-17 6 -0.25 -0.19 -0.29 -0.22
Year Ending Dec-17 6 -1.12 -1.02 -1.20 -1.08
Year Ending Dec-18 6 -0.83 -0.64 -1.31 -0.34

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-17 2.27 2.66 0.39 17.28
Quarter Ending Mar-17 1.80 3.11 1.30 72.32
Quarter Ending Dec-16 3.71 6.43 2.73 73.53
Quarter Ending Sep-16 2.89 3.37 0.48 16.60
Quarter Ending Jun-16 2.17 4.53 2.36 108.47
Earnings (per share)
Quarter Ending Jun-17 -0.28 -0.29 0.01 -2.95
Quarter Ending Mar-17 -0.27 -0.34 0.07 -26.72
Quarter Ending Dec-16 -0.23 -0.21 0.03 -10.64
Quarter Ending Sep-16 -0.23 -0.25 0.02 -7.16
Quarter Ending Jun-16 -0.22 -0.24 0.02 -9.09

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 2.22 2.22 2.22 2.45 0.89
Quarter Ending Dec-17 2.84 2.84 2.84 2.84 0.94
Year Ending Dec-17 10.65 10.65 10.65 10.63 7.41
Year Ending Dec-18 29.70 29.70 29.70 30.85 53.66
Earnings (per share)
Quarter Ending Sep-17 -0.27 -0.27 -0.27 -0.27 -0.23
Quarter Ending Dec-17 -0.25 -0.25 -0.25 -0.26 -0.22
Year Ending Dec-17 -1.12 -1.12 -1.12 -1.15 -1.08
Year Ending Dec-18 -0.83 -0.83 -0.83 -0.86 -0.34

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-17 0 0 0 0
Quarter Ending Dec-17 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings
Quarter Ending Sep-17 0 0 0 0
Quarter Ending Dec-17 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0